SEFFIHAIR®️
SEFFIHAIR®️ The PROTOCOL designed to TREAT non-atrophic hair follicles, resulting in REGROWTH, THICKENING and improvement of HAIR QUALITY
HAIR THINNING, EITHER LOCALIZED OR WIDESPREAD, IS CLASSIFIED WITH THE NAME OF ANDROGENETIC ALOPECIA
The follicle weakens, the hair becomes thinner, sparser, until it falls.
The cause is often multifactorial and includes stress, lack of micro or macro nutrients, incorrect lifestyles and above all it is produced by the synergy of two molecules that, in the case of genetically predisposed subjects, damages the hair bulb until its function is inhibited or its functionality reduced.
These two substances are:
dihydrotestorone (DHT), derived from the hormone testosterone
prostaglandins D2 (PGD2), which are mediators of inflammation
Their synergistic action damages the follicles of genetically predisposed people.
85% of men and 40% of women suffer from ANDROGENETIC ALOPECIA (1).
Today ANDROGENETIC ALOPECIA is a pathology that can be treated with a combined protocol, where the most important component is REGENERATIVE MEDICINE.
The aim of the REGENERATIVE MEDICINE is to reactivate the non-atrophic follicles (hair regrowth) and to strengthen the weak follicles that generate inaesthetic thin hair.
WOMEN SUFFER FROM ANDROGENETIC ALOPECIA AS WELL
40% of women of all ethnic groups suffer from androgenetic alopecia (1) or in any case a reduction in the hair density and thickness.
Female alopecia is experienced as a real social problem and not just an aesthetic one. Unfortunately, anxiety and depression are not uncommon among women who suffer from hair loss.
Hair is a fundamental element of personality and it should be treated, protected and maintained healthy over time. Hair is one of the most powerful forms of femininity, a heritage to be protected or rediscovered.
FEMALE HAIR LOSS CAN BE TREATED
Advanced Regenerative Medicine is an available treatment and the most modern and advanced concept to work effectively on androgenetic female alopecia.
(1) Chen, S., Xie, X., Zhang, G. et al. Comorbidities in Androgenetic Alopecia: A Comprehensive Review. Dermatol Ther (Heidelb) 12, 2233–2247 (2022). https://doi.org/10.1007/s13555-022-00799-7